Literature DB >> 33569603

Factor XIII cross-links fibrin(ogen) independent of fibrin polymerization in experimental acute liver injury.

Lauren G Poole1,2, Anna K Kopec1,2, Dafna J Groeneveld1,2, Asmita Pant1,2, Kevin S Baker2,3, Holly M Cline-Fedewa1, Matthew J Flick4, James P Luyendyk1,2,3.   

Abstract

Intravascular fibrin clot formation follows a well-ordered series of reactions catalyzed by thrombin cleavage of fibrinogen leading to fibrin polymerization and cross-linking by factor XIIIa (FXIIIa). Extravascular fibrin(ogen) deposits are observed in injured tissues; however, the mechanisms regulating fibrin(ogen) polymerization and cross-linking in this setting are unclear. The objective of this study was to determine the mechanisms of fibrin polymerization and cross-linking in acute liver injury induced by acetaminophen (APAP) overdose. Hepatic fibrin(ogen) deposition and cross-linking were measured following APAP overdose in wild-type mice, mice lacking the catalytic subunit of FXIII (FXIII-/-), and in FibAEK mice, which express mutant fibrinogen insensitive to thrombin-mediated fibrin polymer formation. Hepatic fibrin(ogen) deposition was similar in APAP-challenged wild-type and FXIII-/- mice, yet cross-linking of hepatic fibrin(ogen) was dramatically reduced (>90%) by FXIII deficiency. Surprisingly, hepatic fibrin(ogen) deposition and cross-linking were only modestly reduced in APAP-challenged FibAEK mice, suggesting that in the APAP-injured liver fibrin polymerization is not strictly required for the extravascular deposition of cross-linked fibrin(ogen). We hypothesized that the oxidative environment in the injured liver, containing high levels of reactive mediators (eg, peroxynitrite), modifies fibrin(ogen) such that fibrin polymerization is impaired without impacting FXIII-mediated cross-linking. Notably, fibrin(ogen) modified with 3-nitrotyrosine adducts was identified in the APAP-injured liver. In biochemical assays, peroxynitrite inhibited thrombin-mediated fibrin polymerization in a concentration-dependent manner without affecting fibrin(ogen) cross-linking over time. These studies depict a unique pathology wherein thrombin-catalyzed fibrin polymerization is circumvented to allow tissue deposition and FXIII-dependent fibrin(ogen) cross-linking.
© 2021 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33569603      PMCID: PMC8109015          DOI: 10.1182/blood.2020007415

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

1.  Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.

Authors:  K R Siebenlist; D A Meh; M W Mosesson
Journal:  Thromb Haemost       Date:  2001-11       Impact factor: 5.249

Review 2.  Newly-Recognized Roles of Factor XIII in Thrombosis.

Authors:  James R Byrnes; Alisa S Wolberg
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

Review 3.  Rebalanced Hemostasis in Patients with Acute Liver Failure.

Authors:  Ton Lisman; R Todd Stravitz
Journal:  Semin Thromb Hemost       Date:  2015-06-06       Impact factor: 4.180

4.  Platelets and protease-activated receptor-4 contribute to acetaminophen-induced liver injury in mice.

Authors:  Kazuhisa Miyakawa; Nikita Joshi; Bradley P Sullivan; Ryan Albee; Christina Brandenberger; Hartmut Jaeschke; Mitchell R McGill; Michael A Scott; Patricia E Ganey; James P Luyendyk; Robert A Roth
Journal:  Blood       Date:  2015-07-15       Impact factor: 22.113

5.  Fibrin(ogen)-independent role of plasminogen activators in acetaminophen-induced liver injury.

Authors:  Bradley P Sullivan; Karen M Kassel; Alice Jone; Matthew J Flick; James P Luyendyk
Journal:  Am J Pathol       Date:  2012-04-13       Impact factor: 4.307

6.  Influences of reactive oxygen species and nitric oxide on hepatic fibrogenesis.

Authors:  Gennadiy Novitskiy; James J Potter; Lan Wang; Esteban Mezey
Journal:  Liver Int       Date:  2006-12       Impact factor: 5.828

7.  Fibrin(ogen) drives repair after acetaminophen-induced liver injury via leukocyte αMβ2 integrin-dependent upregulation of Mmp12.

Authors:  Anna K Kopec; Nikita Joshi; Holly Cline-Fedewa; Anna V Wojcicki; Jessica L Ray; Bradley P Sullivan; John E Froehlich; Brendan F Johnson; Matthew J Flick; James P Luyendyk
Journal:  J Hepatol       Date:  2016-12-10       Impact factor: 25.083

8.  The interaction between fibrinogen and zymogen FXIII-A2B2 is mediated by fibrinogen residues γ390-396 and the FXIII-B subunits.

Authors:  James R Byrnes; Clare Wilson; Anthony M Boutelle; Chase B Brandner; Matthew J Flick; Helen Philippou; Alisa S Wolberg
Journal:  Blood       Date:  2016-08-25       Impact factor: 22.113

9.  Ca2+-related regulatory function of fibrinogen.

Authors:  R B Credo; C G Curtis; L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

10.  A fibrin biofilm covers blood clots and protects from microbial invasion.

Authors:  Fraser L Macrae; Cédric Duval; Praveen Papareddy; Stephen R Baker; Nadira Yuldasheva; Katherine J Kearney; Helen R McPherson; Nathan Asquith; Joke Konings; Alessandro Casini; Jay L Degen; Simon D Connell; Helen Philippou; Alisa S Wolberg; Heiko Herwald; Robert As Ariëns
Journal:  J Clin Invest       Date:  2018-06-25       Impact factor: 14.808

View more
  2 in total

1.  Cross-linking by tissue transglutaminase-2 alters fibrinogen-directed macrophage proinflammatory activity.

Authors:  Lauren G Poole; Anna K Kopec; Matthew J Flick; James P Luyendyk
Journal:  J Thromb Haemost       Date:  2022-02-27       Impact factor: 16.036

2.  SARS-CoV-2 infection induces soluble platelet activation markers and PAI-1 in the early moderate stage of COVID-19.

Authors:  Abaher O Al-Tamimi; Ayesha M Yusuf; Manju N Jayakumar; Abdul W Ansari; Mona Elhassan; Fatema AbdulKarim; Meganathan Kannan; Rabih Halwani; Firdos Ahmad
Journal:  Int J Lab Hematol       Date:  2022-03-09       Impact factor: 3.450

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.